Meridian Wealth Management’s Omega Healthcare OHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$239K Buy
5,022
+42
+0.8% +$1.95K 0.01% 740
2026
Q1
$218K Buy
4,980
+3
+0.1% +$137 0.01% 733
2025
Q4
$221K Sell
4,977
-174
-3% -$7.5K 0.01% 696
2025
Q3
$217K Buy
+5,151
New +$208K 0.01% 659
2025
Q1
Sell
-6,020
Closed -$228K 642
2024
Q4
$228K Buy
6,020
+250
+4% +$9.99K 0.01% 576
2024
Q3
$235K Buy
+5,770
New +$218K 0.01% 578
2023
Q4
Sell
-13,834
Closed -$459K 609
2023
Q3
$459K Buy
13,834
+6,917
+100% +$221K 0.03% 384
2023
Q2
$212K Sell
6,917
-1,000
-13% -$28.9K 0.02% 508
2023
Q1
$217K Buy
7,917
+147
+2% +$4.09K 0.02% 494
2022
Q4
$217K Hold
7,770
0.02% 475
2022
Q3
$229K Buy
+7,770
New +$244K 0.02% 427
2019
Q3
Sell
-3,298
Closed -$121K 388
2019
Q2
$121K Buy
+3,298
New +$120K 0.05% 257

Other funds holding OHI

Meridian Wealth Management's OHI Position: Q2 2026 in Review

Meridian Wealth Management increased its Omega Healthcare (OHI) stake by 0.84% in Q2 2026, buying an estimated $1.95K and bringing the position to 5,022 shares worth $239K. The position accounts for 0.01% of the portfolio, ranked #740.

Meridian Wealth Management first reported a position in OHI in Q2 2019 and has held it in 12 quarters since. The position peaked at $459K in Q3 2023. 761 funds tracked by Wall St. Rank hold OHI as of Q2 2026.

  • Meridian Wealth Management held 5,022 shares of Omega Healthcare worth $239K as of Q2 2026.
  • Meridian Wealth Management bought 42 Omega Healthcare shares in Q2 2026, an estimated $1.95K.
  • Omega Healthcare made up 0.01% of Meridian Wealth Management's portfolio in Q2 2026, its #740 holding.
  • Meridian Wealth Management first reported a position in Omega Healthcare in Q2 2019 and has held it in 12 quarters since.
  • Meridian Wealth Management's Omega Healthcare position peaked at $459K in Q3 2023.
  • 761 funds tracked by Wall St. Rank held Omega Healthcare as of Q2 2026.

Based on Meridian Wealth Management's 13F filing for Q2 2026, filed 5 Aug 2026.